JMJD5, a Jumonji C (JmjC) Domain-containing Protein, Negatively Regulates Osteoclastogenesis by Facilitating NFATc1 Protein Degradation*
JMJD5, a Jumonji C (JmjC) Domain-containing Protein, Negatively Regulates Osteoclastogenesis by Facilitating NFATc1 Protein Degradation*
复制标题
DOI：
10.1074/jbc.m111.323105
复制
发表时间：
2012-02
期刊：
影响因子：
--
通讯作者：
Min-young Youn;A. Yokoyama;Sally Fujiyama-Nakamura;F. Ohtake;K. Minehata;H. Yasuda;Takeshisa Suzuki
中科院分区：
文献类型：
--
作者：
Min-young Youn;A. Yokoyama;Sally Fujiyama-Nakamura;F. Ohtake;K. Minehata;H. Yasuda;Takeshisa Suzuki
Background: NFATc1 is a necessary and sufficient transcription factor for osteoclastogenesis. Results: JMJD5 negatively regulates NFATc1 protein level through its hydroxylase activity. Conclusion: JMJD5 is a novel osteoclastogenic repressor that induces the degradation of NFATc1 protein. Significance: This study revealed a novel mechanism that regulates NFATc1 activity during osteoclastogenesis. Osteoclastogenesis is a highly regulated process governed by diverse classes of regulators. Among them, nuclear factor of activated T-cells calcineurin-dependent 1 (NFATc1) is the primary osteoclastogenic transcription factor, and its expression is transcriptionally induced during early osteoclastogenesis by receptor activation of nuclear factor κB ligand (RANKL), an osteoclastogenic cytokine. Here, we report the novel enzymatic function of JMJD5, which regulates NFATc1 protein stability. Among the tested Jumonji C (JmjC) domain-containing proteins, decreased mRNA expression levels during osteoclastogenesis were found for JMJD5 in RAW264 cells stimulated by RANKL. To examine the functional role of JMJD5 in osteoclast differentiation, we established stable JMJD5 knockdown cells, and osteoclast formation was assessed. Down-regulated expression of JMJD5 led to accelerated osteoclast formation together with induction of several osteoclast-specific genes such as Ctsk and DC-STAMP, suggesting that JMJD5 is a negative regulator in osteoclast differentiation. Although JMJD5 was recently reported as a histone demethylase for histone H3K36me2, no histone demethylase activity was detected in JMJD5 in vitro or in living cells, even for other methylated histone residues. Instead, JMJD5 co-repressed transcriptional activity by destabilizing NFATc1 protein. Protein hydroxylase activity mediated by the JmjC domain in JMJD5 was required for the observed functions of JMJD5. JMJD5 induced the association of hydroxylated NFATc1 with the E3 ubiquitin ligase Von Hippel-Lindau tumor suppressor (VHL), thereby presumably facilitating proteasomal degradation of NFATc1 via ubiquitination. Taken together, the present study demonstrated that JMJD5 is a post-translational co-repressor for NFATc1 that attenuates osteoclastogenesis.
